Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 5/20 | 0.42 |
| ▸ | LSS | P48449 | 4/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27467452 | 0.89 | SLC6A4 (0.39) | SLC6A4SLC6A2SLC6A3FFAR4 | |
| SCHEMBL27466552 | 0.79 | SLC6A4 (0.38) | SLC6A4MAOASLC6A2SLC6A3 | |
| SCHEMBL7319768 | 0.76 | SLC6A4 (0.45) | SLC6A4LSSSLC6A2SLC6A3 | |
| SCHEMBL9512625 | 0.72 | AKR1C3 (0.48) | — | |
| SCHEMBL27468419 | 0.70 | SLC6A4 (0.32) | SLC6A4 | |
| SCHEMBL17350051 | 0.68 | SLC6A4 (0.43) | SLC6A4 | |
| Hydrochloric Acid SCHEMBL4533102 | 0.68 | ALDH1A1 (0.49) | SLC6A4MAOA | |
| SCHEMBL19715652 | 0.68 | ALDH1A1 (0.49) | SLC6A4MAOA | |
| Acetonitrile SCHEMBL7968109 | 0.68 | SIGMAR1 (0.47) | FFAR4 | |
| SCHEMBL7411787 | 0.67 | SLC6A4 (0.47) | SLC6A4MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1154483-C | Use of amines to produce drugs for preventing tumour cell proliferation | ��ŵ��-ʥ�������ɷ�����˾ | 2004-06-23 | — | — | CN | disclosed |
| CN-1226825-A | Use of amines to produce drugs for preventing tumour cell proliferation | SANOFI SA (FR) | 1999-08-25 | — | — | CN | disclosed |